白藜蘆醇 Resveratrol × 心血管疾病
The entire cardiovascular evidence base for resveratrol rests on surrogate markers (blood pressure, lipids, CRP, TNF-alpha, flow-mediated dilation) — there is no hard-outcome RCT measuring MACE, cardiovascular mortality, or hospitalization.
The entire cardiovascular evidence base for resveratrol rests on surrogate markers (blood pressure, lipids, CRP, TNF-alpha, flow-mediated dilation) — there is no hard-outcome RCT measuring MACE, cardiovascular mortality, or hospitalization. Meta-analyses (L2) show only small, heterogeneous improvements in these surrogates, with benefits largely confined to metabolic-syndrome subgroups and minimal effect in healthy subjects. Independent clinical authorities are consistently skeptical: Harvard Health states there is zero evidence of benefit from supplementation and cites a 2014 JAMA cohort finding no link between dietary resveratrol and CVD events or mortality; Mayo and Cleveland call the evidence mixed and note poor bioavailability; AHA does not endorse it and ACC effectively concludes against it. Examine's per-outcome B grades reflect surrogate-marker meta-analyses but do not establish clinical CVD benefit, so a totality-of-evidence read places this firmly at C — evidence exists but is small, inconsistent, surrogate-only, and of uncertain clinical significance. The famous French paradox / red-wine narrative is a marketing artifact unsupported by trial evidence.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.574
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
台灣社群（PTT BeautySalon/WomenTalk/regimen、Dcard、Mobile01）對白藜蘆醇的討論幾乎全部集中在抗老抗氧化、養顏美容、氣色精神、助眠，以及備孕/子宮肌瘤調理，並常與 NMN 並列為『逆齡聖品』；幾乎沒有以『心血管疾病』為主訴的真實使用心得。實測心得集中於『吃了人比較有精神、氣色變好、比較好入眠』，沒有人回報降血壓/降膽固醇有感。心血管功效僅以『紅酒護心／法國悖論』作為背景知識被轉述，且此說法的源頭研究者 Dipak K. Das 已被踢爆造假（145 筆數據造假、26 篇論文撤回），社群層面就此 condition 屬冷門無真實討論，相關護心宣稱多來自受業配與 iHerb affiliate 污染的商業健康媒體與直銷話術。
無共識（社群幾乎不以心血管為由討論白藜蘆醇；『有感』心得集中於精神、氣色與睡眠等抗老美容面向，沒有人回報針對心血管疾病的親身有感效果）
- 社群實測心得普遍未回報明顯副作用
- 孕婦／哺乳／備孕者為標示禁忌族群（非副作用，屬使用限制）
- 高劑量膠囊（如 150mg）體積偏大、吞嚥困難（適口性問題，零星提及）
依論壇被提及頻率，非銷售或品質排序。
- 永活醇（PTT 心得中最有感，150mg/顆，膠囊偏大）
- 大醫生技 葡萄萃取白藜蘆醇膠囊（80mg/顆）
- BHK's 白藜蘆醇素食膠囊（40mg/顆，含 OPC，多人覺得雞肋）
- 赫而司 Herz
- 倍韻
- 凱洛
- iHerb 通路（Doctor's Best 等反式白藜蘆醇，affiliate 推文密集）
- Isotonix 美安（直銷管道）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 生活型態優化（健康飲食、身體活動、戒菸）
- 史他汀類藥物（適應症族群）
- 戒菸（行為介入合併藥物）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cardiovascular-disease-INT-resveratrol-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "白藜蘆醇能改善心血管疾病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}